title: Meningococcal B disease: assessment and management.
abstract: Serogroup B meningococcal disease is the last main cause of bacterial meningitis and septicaemia in the UK. There is currently no vaccine against this serogroup. This article outlines the nature of meningococcal disease and highlights recent guidance from the National Institute for Health and Clinical Excellence on recognising and managing the disease in primary and secondary care. An update on progress towards a preventive vaccine is also discussed.
authors.affiliation: A Talent 4 Health Limited, Cheltenham. info@talent4health.co.uk
authors.forename: Adrienne
authors.initials: A
authors.lastname: Willcox
mesh_terms: D004496:Education, Continuing; D006801:Humans; D008589:Meningococcal Infections / Q000175:diagnosis* / Q000628:therapy* / Q000635:transmission; D012307:Risk Factors; D006113:United Kingdom